Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5434)
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,731
Price
$18.91
Total Value
$32.73K
Shares Held After
56,630
% of Holdings
3.1%
Twist Bioscience Corp (TWST)
CHESS ROBERT — Director
Shares
10,000
Price
$47.00
Total Value
$470.00K
Shares Held After
21,084
% of Holdings
32.2%
MAXCYTE, INC. (MXCT)
Swirsky Douglas J — CHIEF FINANCIAL OFFICER
Shares
10,142
Price
$0.81
Total Value
$8.27K
Shares Held After
151,669
% of Holdings
6.3%
Evolus, Inc. (EOLS)
MOATAZEDI DAVID — Director
Shares
116,720
Price
$4.89
Total Value
$570.56K
Shares Held After
618,369
% of Holdings
15.9%
Evolus, Inc. (EOLS)
Avelar Rui — Chief Medical Officer and Head of Research & Development
Shares
29,996
Price
$4.89
Total Value
$146.63K
Shares Held After
430,542
% of Holdings
6.5%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
405
Price
$56.26
Total Value
$22.79K
Shares Held After
28,975
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
1,487
Price
$55.39
Total Value
$82.36K
Shares Held After
29,380
% of Holdings
4.8%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
10,043
Price
$28.10
Total Value
$282.21K
Shares Held After
62,085
% of Holdings
13.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.40
Total Value
$255.40K
Shares Held After
499,258
% of Holdings
3.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
22,290
Price
$50.73
Total Value
$1.13M
Shares Held After
17,044
% of Holdings
56.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
27,710
Price
$49.95
Total Value
$1.38M
Shares Held After
39,334
% of Holdings
41.3%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
10,172
Price
$73.21
Total Value
$744.66K
Shares Held After
82,660
% of Holdings
11.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
23,928
Price
$62.15
Total Value
$1.49M
Shares Held After
430,330
% of Holdings
5.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
12,673
Price
$62.15
Total Value
$787.63K
Shares Held After
454,258
% of Holdings
2.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
4,397
Price
$62.15
Total Value
$273.27K
Shares Held After
153,902
% of Holdings
2.8%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
7,636
Price
$62.15
Total Value
$474.58K
Shares Held After
158,299
% of Holdings
4.6%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,916
Price
$62.15
Total Value
$181.23K
Shares Held After
71,573
% of Holdings
3.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$538.41
Total Value
$587.40K
Shares Held After
43,082
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.32
Total Value
$537.32K
Shares Held After
44,173
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$536.26
Total Value
$986.71K
Shares Held After
45,173
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$535.05
Total Value
$388.98K
Shares Held After
47,013
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,076
Price
$534.14
Total Value
$574.74K
Shares Held After
47,740
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
667
Price
$533.16
Total Value
$355.62K
Shares Held After
48,816
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$532.24
Total Value
$211.30K
Shares Held After
49,483
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$531.21
Total Value
$70.65K
Shares Held After
49,880
% of Holdings
0.3%
TANDEM DIABETES CARE INC (TNDM)
Novara Mark David — EVP & CHIEF COMMERCIAL OFFICER
Shares
187
Price
$23.05
Total Value
$4.31K
Shares Held After
37,656
% of Holdings
0.5%
Esperion Therapeutics, Inc. (ESPR)
Looker Benjamin — Chief Legal Officer
Shares
5,708
Price
$2.70
Total Value
$15.43K
Shares Held After
679,348
% of Holdings
0.8%
Esperion Therapeutics, Inc. (ESPR)
Halladay Benjamin — Chief Financial Officer
Shares
6,424
Price
$2.71
Total Value
$17.38K
Shares Held After
713,602
% of Holdings
0.9%
Esperion Therapeutics, Inc. (ESPR)
Koenig Sheldon L. — Director
Shares
25,578
Price
$2.72
Total Value
$69.55K
Shares Held After
2,172,699
% of Holdings
1.2%
Hims & Hers Health, Inc. (HIMS)
Becklund Irene — PAO
Shares
5,529
Price
$24.69
Total Value
$136.51K
Shares Held After
8,752
% of Holdings
38.7%
Hims & Hers Health, Inc. (HIMS)
Chi Michael — Chief Operating Officer
Shares
97,289
Price
$24.69
Total Value
$2.40M
Shares Held After
407,282
% of Holdings
19.3%
Hims & Hers Health, Inc. (HIMS)
Boughton Soleil — Chief Legal Officer
Shares
4,812
Price
$24.69
Total Value
$118.81K
Shares Held After
308,831
% of Holdings
1.5%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
2,500
Price
$102.43
Total Value
$256.08K
Shares Held After
2,240,000
% of Holdings
0.1%
HARVARD BIOSCIENCE INC (HBIO)
DENELSKY STEPHEN J — Director
Shares
10,000
Price
$4.87
Total Value
$48.70K
Shares Held After
21,000
% of Holdings
47.6%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
531,000
Price
$1.16
Total Value
$615.96K
Shares Held After
7,516,404
% of Holdings
7.1%
Nutex Health Inc. (NUTX)
Spears Kelvin — Director
Shares
10
Price
$94.46
Total Value
$944.60
Shares Held After
32,137
% of Holdings
0.0%
Airsculpt Technologies, Inc. (AIRS)
Chernett Jorey — 10% Owner
Shares
83,000
Price
$2.56
Total Value
$212.48K
Shares Held After
6,676,059
% of Holdings
1.2%
HARVARD BIOSCIENCE INC (HBIO)
Snider William — Director
Shares
8,475
Price
$4.85
Total Value
$41.10K
Shares Held After
32,000
% of Holdings
26.5%
IRONWOOD PHARMACEUTICALS INC (IRWD)
DENNER ALEXANDER J — Director
Shares
5,800
Price
$3.31
Total Value
$19.20K
Shares Held After
9,188,635
% of Holdings
0.1%
IRONWOOD PHARMACEUTICALS INC (IRWD)
DENNER ALEXANDER J — Director
Shares
6,725,000
Price
$3.05
Total Value
$20.51M
Shares Held After
9,194,435
% of Holdings
42.2%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$25.65
Total Value
$10.70K
Shares Held After
76,140
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
45
Price
$533.51
Total Value
$24.01K
Shares Held After
125
% of Holdings
26.5%
EKSO BIONICS HOLDINGS, INC. (EKSO)
Jones Jason C — Chief Operating Officer
Shares
1,308
Price
$11.85
Total Value
$15.50K
Shares Held After
4,449
% of Holdings
29.4%
Showing 351–400 of 5434 transactions (page 8 of 109)